The AMR Action Fund has moved into its new European office in Basel. The venture fund is the largest public-private partnership for the development…
BEAM Alliance has released a new position paper outlining five pillars for an effective AMR pull incentive mechanism in Europe from the SME perspective.…
A total of four ventures, three from Germany and one from Finland, have been selected by the Swiss-based AMR-focused incubator INCATE. They will receive…
The German government has released its policy priorities for the G7 Presidency in 2022 and confirmed that antimicrobial resistance will be part of it.…
Don’t miss to participate in the start-up competition @AMR conference supported by INCATE. Early-stage ventures fighting drug resistant bacterial infections in the therapeutics or diagnostics…
In December, a consortium of 8 public and 4 private Swiss institutions has joined forces to address the silent pandemic of AMR by launching…
Pharma company Roche is among the partners of AMR-focused incubator INCATE. We spoke with Rusudan Okujava about the motivation of Roche to support the…
In late December, FIND announced an investment of US$21 million to accelerate the development, manufacturing, and launch of affordable, multi-pathogen, molecular diagnostic platforms, specifically…
On the occasion of the World Antibiotic Awareness Week (WAAW), BEAM Alliance has published a series of comics illustrating behind the scenes impressions of…
